Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.56
(-2.36%)
CNY 4.56
(-2.36%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -83.34 Million CNY | -108.02% |
| 2022 | 22 Million CNY | -18.76% |
| 2021 | 58.1 Million CNY | 136.12% |
| 2020 | -924.82 Million CNY | 42.93% |
| 2019 | -703.12 Million CNY | -195.7% |
| 2018 | 395.78 Million CNY | 4.95% |
| 2017 | 437.32 Million CNY | -31.01% |
| 2016 | 536 Million CNY | 12.28% |
| 2015 | 483.77 Million CNY | 44.42% |
| 2014 | 364.3 Million CNY | 1438.92% |
| 2013 | 190.83 Million CNY | 261.07% |
| 2012 | -31.79 Million CNY | 43.18% |
| 2011 | -27.46 Million CNY | -161.43% |
| 2010 | 32.76 Million CNY | 173.11% |
| 2009 | -187.88 Million CNY | -446.02% |
| 2008 | 12.73 Million CNY | -62.15% |
| 2007 | 40.57 Million CNY | 0.3% |
| 2006 | 45.59 Million CNY | 23.51% |
| 2005 | 36.17 Million CNY | 216.31% |
| 2004 | -31.1 Million CNY | -45.29% |
| 2003 | -21.4 Million CNY | -158.74% |
| 2002 | 36.44 Million CNY | 38.83% |
| 2001 | 26.25 Million CNY | -61.58% |
| 2000 | 61.96 Million CNY | 50.69% |
| 1999 | 45.34 Million CNY | 60.55% |
| 1998 | 27.38 Million CNY | 23.97% |
| 1997 | 22.78 Million CNY | 69.68% |
| 1996 | 13.42 Million CNY | 33.66% |
| 1995 | 10.04 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -11.82 Million CNY | -157.17% |
| 2024 Q1 | 7.11 Million CNY | 114.59% |
| 2024 Q3 | -78.55 Million CNY | -564.2% |
| 2023 Q2 | 8.5 Million CNY | -46.16% |
| 2023 Q4 | -70.55 Million CNY | -1743.55% |
| 2023 Q1 | 15.8 Million CNY | 158.79% |
| 2023 FY | - CNY | -108.02% |
| 2023 Q3 | -3.82 Million CNY | -144.97% |
| 2022 Q1 | 21.87 Million CNY | 135.74% |
| 2022 Q2 | 13.86 Million CNY | -36.62% |
| 2022 Q3 | 5.61 Million CNY | -59.47% |
| 2022 FY | - CNY | -18.76% |
| 2022 Q4 | -26.88 Million CNY | -578.6% |
| 2021 Q3 | -41.19 Million CNY | -200.99% |
| 2021 Q4 | -61.18 Million CNY | -48.51% |
| 2021 FY | - CNY | 136.12% |
| 2021 Q1 | 40.12 Million CNY | 107.27% |
| 2021 Q2 | 40.79 Million CNY | 1.68% |
| 2020 Q3 | 7.98 Million CNY | -95.76% |
| 2020 FY | - CNY | 42.93% |
| 2020 Q1 | 35.96 Million CNY | 108.51% |
| 2020 Q2 | 188.6 Million CNY | 424.47% |
| 2020 Q4 | -552.03 Million CNY | -7010.62% |
| 2019 Q2 | 77.91 Million CNY | 78.54% |
| 2019 FY | - CNY | -195.7% |
| 2019 Q4 | -422.47 Million CNY | -111.76% |
| 2019 Q3 | -199.5 Million CNY | -356.05% |
| 2019 Q1 | 43.64 Million CNY | -62.5% |
| 2018 Q4 | 116.39 Million CNY | 63.53% |
| 2018 Q1 | 82.61 Million CNY | 47.16% |
| 2018 Q3 | 71.17 Million CNY | -11.47% |
| 2018 FY | - CNY | 4.95% |
| 2018 Q2 | 80.39 Million CNY | -2.69% |
| 2017 Q2 | 90.06 Million CNY | 13.05% |
| 2017 FY | - CNY | -31.01% |
| 2017 Q1 | 79.66 Million CNY | -71.4% |
| 2017 Q4 | 56.14 Million CNY | -43.08% |
| 2017 Q3 | 98.63 Million CNY | 9.51% |
| 2016 FY | - CNY | 12.28% |
| 2016 Q2 | 119.51 Million CNY | 69.39% |
| 2016 Q4 | 278.54 Million CNY | 226.53% |
| 2016 Q1 | 70.55 Million CNY | -67.68% |
| 2016 Q3 | 85.3 Million CNY | -28.62% |
| 2015 Q1 | 73.82 Million CNY | -79.56% |
| 2015 Q3 | 106.75 Million CNY | 13.55% |
| 2015 Q4 | 218.31 Million CNY | 104.51% |
| 2015 FY | - CNY | 44.42% |
| 2015 Q2 | 94.01 Million CNY | 27.34% |
| 2014 Q2 | -8.13 Million CNY | -16.98% |
| 2014 FY | - CNY | 1438.92% |
| 2014 Q4 | 361.15 Million CNY | 10191.7% |
| 2014 Q3 | -3.57 Million CNY | 56.0% |
| 2014 Q1 | -6.95 Million CNY | -127.83% |
| 2013 Q1 | -6.8 Million CNY | 32.17% |
| 2013 Q3 | 5.78 Million CNY | 1285.35% |
| 2013 FY | - CNY | 261.07% |
| 2013 Q4 | 24.98 Million CNY | 332.18% |
| 2013 Q2 | 417.23 Thousand CNY | 106.13% |
| 2012 Q3 | -6.82 Million CNY | -300.1% |
| 2012 FY | - CNY | 43.18% |
| 2012 Q2 | -1.7 Million CNY | 67.25% |
| 2012 Q1 | -5.21 Million CNY | 55.46% |
| 2012 Q4 | -10.03 Million CNY | -46.95% |
| 2011 Q1 | -8.4 Million CNY | -119.85% |
| 2011 Q2 | -2.92 Million CNY | 65.14% |
| 2011 Q3 | -9.19 Million CNY | -213.9% |
| 2011 FY | - CNY | -161.43% |
| 2011 Q4 | -11.7 Million CNY | -27.27% |
| 2010 Q4 | 42.32 Million CNY | 923.97% |
| 2010 FY | - CNY | 173.11% |
| 2010 Q2 | 747.91 Thousand CNY | 139.66% |
| 2010 Q1 | -1.88 Million CNY | 97.11% |
| 2010 Q3 | -5.13 Million CNY | -786.81% |
| 2009 Q3 | -3.51 Million CNY | -15.6% |
| 2009 FY | - CNY | -446.02% |
| 2009 Q2 | -3.04 Million CNY | 59.77% |
| 2009 Q1 | -7.55 Million CNY | 76.63% |
| 2009 Q4 | -65.15 Million CNY | -1753.38% |
| 2008 FY | - CNY | -62.15% |
| 2008 Q3 | 9.78 Million CNY | -18.27% |
| 2008 Q2 | 11.97 Million CNY | 35.54% |
| 2008 Q4 | -32.35 Million CNY | -430.58% |
| 2008 Q1 | 8.83 Million CNY | -22.13% |
| 2007 Q3 | 5.48 Million CNY | 6.57% |
| 2007 Q1 | 8.49 Million CNY | -29.34% |
| 2007 Q4 | 11.34 Million CNY | 106.82% |
| 2007 FY | - CNY | 0.3% |
| 2007 Q2 | 5.14 Million CNY | -39.42% |
| 2006 Q4 | 12.02 Million CNY | 11.07% |
| 2006 Q2 | 12.07 Million CNY | 22.36% |
| 2006 Q1 | 9.86 Million CNY | -25.78% |
| 2006 FY | - CNY | 23.51% |
| 2006 Q3 | 10.82 Million CNY | -10.32% |
| 2005 Q2 | 6.5 Million CNY | -38.09% |
| 2005 Q3 | 8.05 Million CNY | 23.86% |
| 2005 FY | - CNY | 216.31% |
| 2005 Q4 | 13.29 Million CNY | 65.1% |
| 2005 Q1 | 10.49 Million CNY | 121.14% |
| 2004 Q3 | 2.08 Million CNY | -83.43% |
| 2004 Q1 | 8.47 Million CNY | 115.25% |
| 2004 Q2 | 12.57 Million CNY | 48.34% |
| 2004 Q4 | -49.66 Million CNY | -2483.82% |
| 2004 FY | - CNY | -45.29% |
| 2003 Q1 | 5.7 Million CNY | -54.71% |
| 2003 FY | - CNY | -158.74% |
| 2003 Q4 | -55.6 Million CNY | -660.76% |
| 2003 Q3 | 9.91 Million CNY | -20.98% |
| 2003 Q2 | 12.54 Million CNY | 119.89% |
| 2002 Q1 | 2.6 Million CNY | 0.0% |
| 2002 FY | - CNY | 38.83% |
| 2002 Q4 | 12.59 Million CNY | 333.29% |
| 2002 Q3 | 2.9 Million CNY | -65.57% |
| 2002 Q2 | 8.44 Million CNY | 224.68% |
| 2001 FY | - CNY | -61.58% |
| 2000 FY | - CNY | 50.69% |
| 1999 FY | - CNY | 60.55% |
| 1998 FY | - CNY | 23.97% |
| 1997 FY | - CNY | 69.68% |
| 1996 FY | - CNY | 33.66% |
| 1995 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.14 Billion CNY | 107.3% |
| Zhejiang Zhenyuan Share Co., Ltd. | 220.46 Million CNY | 137.804% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -2.67 Million CNY | -3019.429% |
| Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 82.764% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | 225.989% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 4.85 Billion CNY | 101.716% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | 171.542% |
| Boai NKY Medical Holdings Ltd. | 665.28 Million CNY | 112.527% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | 121.31% |